+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Attenuation of compensatory right ventricular hypertrophy and heart failure following monocrotaline-induced pulmonary vascular injury by the Na+-H+ exchange inhibitor cariporide

Attenuation of compensatory right ventricular hypertrophy and heart failure following monocrotaline-induced pulmonary vascular injury by the Na+-H+ exchange inhibitor cariporide

Journal of Pharmacology and Experimental Therapeutics 298(2): 469-476

Pulmonary hypertension results in compensatory right ventricular (RV) hypertrophy. We studied the role of the Na+-H+ exchange (NHE) in the latter process by determining the effect of the NHE-1 inhibitor cariporide after monocrotaline-induced pulmonary artery injury. Sprague-Dawley rats received a control or cariporide diet for 7 days, at which time they were administered either monocrotaline (60 mg/kg) or its vehicle. Twenty-one days later, monocrotaline control, but not cariporide-fed animals, demonstrated increased RV weights and cell size of 65 and 52%, respectively. Monocrotaline alone significantly increased RV systolic pressure and end diastolic pressure by 70 and 94%, respectively, whereas corresponding values with cariporide were significantly reduced to 33 and 42%. Central venous pressure increased by 414% in control animals, which was significantly reduced by cariporide. Monocrotaline treatment produced a decrease in cardiac output of 28 and 8% in the absence or presence of cariporide (P < 0.05 between groups), respectively. Although body weights were significantly lower in both monocrotaline-treated groups compared with vehicle treatment, with cariporide the net gain in body weight was twice that seen in the monocrotaline-treated animals without cariporide. Monocrotaline also increased RV NHE-1 and atrial natriuretic peptide mRNA expression, which was abrogated by cariporide. Monocrotaline-induced myocardial necrosis, fibrosis, and mononuclear infiltration was completely prevented by cariporide. Cariporide had no effect on monocrotaline-induced pulmonary intimal wall thickening. Our results demonstrate that cariporide directly attenuates myocardial dysfunction after monocrotaline administration independent of pulmonary vascular effects. NHE-1 inhibition may represent an effective adjunctive therapy that selectively targets myocardial hypertrophic responses in pulmonary vascular injury.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 010217559

Download citation: RISBibTeXText

PMID: 11454907

Related references

Effectiveness of indapamide in reversing right ventricular remodelling and hypertrophy secondary to monocrotaline-induced pulmonary vascular injury and hypertension. European Heart Journal 21(Abstract Suppl.): 63, August-September, 2000

Cardioprotective effects of the Na(+)/H(+)-exchange inhibitor cariporide in infarct-induced heart failure. Cardiovascular Research 46(1): 102-110, 2000

Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy. Laboratory Investigation; a Journal of Technical Methods and Pathology 52(3): 298-303, 1985

Effects of fluvastatin on monocrotaline-induced pulmonary vascular remodeling and right ventricular hypertrophy in rats. Practical Pharmacy And Clinical Remedies: 6, 333-335, 2008

Paradoxical amelioration of monocrotaline-induced pulmonary hypertension and right ventricular failure by NOS inhibitor, l-NAME. Circulation 106(19 Suppl.): II 340, 2002

A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). Journal of Molecular and Cellular Cardiology 29(11): 3169-3174, 1997

The NHE1 inhibitor cariporide improves left ventricular morphology and function in rats with chronic heart failure in combination with the ACE inhibitor ramipril. Circulation 106(19 Suppl.): II-292, 2002

Impact of dietary iron restriction on the development of monocrotaline-induced pulmonary vascular remodeling and right ventricular failure in rats. Biochemical and Biophysical Research Communications 436(2): 145-151, 2013

Reduction by enalapril of cardiac hypertrophy and failure is not associated with pulmonary vasodepression but with attenuation of myocardial isoenzyme redistribution in rats treated with monocrotaline. Circulation 86(4 Suppl. 1): I283, 1992

Resveratrol prevents pulmonary trunk remodeling but not right ventricular hypertrophy in monocrotaline-induced pulmonary hypertension. Pathophysiology 23(4): 243-250, 2016

Hydrogen peroxide induced impairment of post-ischemic ventricular function is prevented by the sodiumhydrogen exchange inhibitor Hoe 642 (cariporide). Cardiovascular Research 40(2): 290-296, 1998

Protective effect of Na(+)-H+ exchanger inhibitor cariporide on the injury of vascular endothelial function induced by hypercholesterolemia. Hunan Yi Ke Da Xue Xue Bao 27(1): 13-16, 2002

Effects of phenobarbitone, cinnarizine, and zoxazolamine on the development of right ventricular hypertrophy and hypertensive pulmonary vascular disease in rats treated with monocrotaline. Cardiovascular Research 10(2): 200-205, 1976

Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. Plos one 9(11): E110598, 2014

Arrhythmogenic substrate in hearts of rats with monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. American Journal of Physiology. Heart and Circulatory Physiology 300(6): H2230, 2011